Mungkin ada gunanya. Bagi yang sudah dapat langsung dari USIS, mohon maaf
kalau jadi doubel.

Salam
Adri

----- Original Message -----
From: Public Affairs Section <[EMAIL PROTECTED]>
To: Adri Amiruddin <[EMAIL PROTECTED]>
Sent: Thursday, December 07, 2000 12:16 PM
Subject: Text: USAID Lists Alternatives to DDT to Fight Malaria


> Text: USAID Lists Alternatives to DDT to Fight Malaria
> (Position paper released at toxic substance meeting) (1640)
>
> The U.S. Agency for International Development (USAID) says it has stepped
up efforts in the battle against malaria in the last several years,
including activities to reduce reliance on the controversial pesticide DDT
for controlling the mosquitoes that carry the disease.
>
> The USAID released the position paper in conjunction with an international
meeting being held December 4-9 in Johannesburg, South Africa, to finalize a
global treaty that would curtail use of several persistent organic
pollutants (POPs), including DDT.
>
> DDT, which poses health risks to wildlife and has been found in the milk
of nursing mothers, has been banned in many industrialized countries.  But
more than two dozen countries still rely on the chemical as an effective way
to rid areas of malaria-carrying mosquitoes.  For example, it is used by
countries in Africa, Asia and the Americas, typically to spray the interior
walls of buildings, where mosquitoes often are found.
>
> USAID says it supports several activities related to the development or
implementation of alternatives to DDT use in so-called indoor residual
spraying, as well as efforts for the overall improvement of malaria
prevention and control.
>
> One such activity is an innovative Africa regional public-private venture
that calls for the commercial distribution of insecticide-treated bednets
(ITNs).  "In many areas of Africa, ITNs may provide an effective alternative
to indoor residual spraying," the USAID paper says.  "Insecticide-treated
net studies have shown reductions in child mortality of 17 to 63 percent in
various African countries."
>
> USAID says its expected that more than 30 million African children will be
protected from malaria over the five-year life of the program.
>
> USAID is also involved in an international anti-malaria effort known at
Roll Back Malaria.  Further information is available at
http://www.rbm.who.int/
>
> The paper lists other USAID activities that reduce reliance on DDT, as
well as the agency's accomplishments in the overall battle against malaria.
>
> Following is the text of the USAID paper:
>
> (begin text)
>
> Fifth Session of the Intergovernmental Negotiating Committee
> for a Treaty on Persistent Organic Pollutants (INC-5)
>
> Johannesburg, South Africa, December 4-9, 2000
>
> U.S. Agency for International Development
> Overview of USAID Malaria Program
> December 2000
>
> Since the start of USAID's Infectious Disease Initiative in 1997 the
Agency has stepped up significantly its efforts in the battle against
malaria, especially in developing new technologies and approaches for the
prevention and control of malaria; building malaria control networks among
U.S. government agencies, multi-lateral donors, NGOs and other bilateral
donors; "rolling-out" Roll Back Malaria (RBM); and establishing new malaria
programs in more than 20 countries.  The long-range control of malaria
depends on such integrated approaches and collaboration, as it is clear that
no one method will work everywhere, and collaborative approaches to
developing locally-appropriate interventions are required.
>
> USAID supports activities related to the development and/or implementation
of alternatives to DDT use in Indoor Residual Spraying, as well as efforts
for overall improvement of malaria prevention and control.
>
> DDT alternatives
>
> USAID activities which reduce reliance on DDT include the following three
areas:
>
> THE ROLLING-OUT OF Roll Back Malaria.  Over the past year USAID has worked
closely with the WHO Geneva secretariat for RBM http://www.rbm.who.int/, the
regional offices in Africa, the Western Pacific, PAHO and host of partners
to lay out RBM's agenda and formulate its strategic approach.  USAID has
been especially active in promoting strong operational linkages between RBM
and ongoing maternal and child health programs, such as Integrated
Management of Childhood Illness (IMCI) and SafeMotherhood.  [Fiscal Year
2000 contribution $3.4 million].
>
> THE LAUNCHING OF NetMark.  NetMark http://www.netmarkafrica.org/ is an
innovative Africa regional public-private venture with the home products
giant SC Johnson promoting commercial distribution of insecticide treated
bednets (ITNs).  In many areas of Africa ITNs may provide an effective
alternative to indoor residual spraying.  Insecticide-treated net studies
have shown reductions in child mortality of 17-63% in various African
countries.  Expectations are that more than 30 million African children will
be protected from malaria over the five-year life of the program.  The
public-private partnership should offer unique advantages in providing
sustained and expanded delivery of insecticide treated netting services.
During 2001 product launches are expected in Senegal, Ghana, Nigeria, Uganda
and Zambia.  [FY 2000 contribution $1.75 million].
>
> IMPROVING EFFECTIVENESS OF NATIONAL VECTOR CONTROL PROGRAMS.
Historically, vector control programs have been a mainstay of national
malaria control programs, but increasing resistance to insecticides, high
costs and wasteful practices have limited their effectiveness.  USAID's
Environmental Health Project (EHP) http://www.usaid.gov/environment/ is
working with national malaria control programs in Eritrea and Mozambique to
strategically target operations according to local ecological factors.
These countries have identified priorities for integrated approaches to
malaria control, and USAID is working in partnership with these countries to
build capacity to collect, analyze and use broad-based surveillance data for
more effective control activities.  EHP is also collaborating with WHO/Roll
Back Malaria to develop an assessment tool for vector control programs to be
used with the RBM national assessment process.  USAID is also collaborating
with WHO/AFRO in addressing the lac!
> k of entomology and vector control program management skills in the field.
[FY 2000 contribution $800,000].
>
> USAID's overall malaria efforts
>
> In addition to these programs, USAID has a long-standing commitment to
improving malaria control through a variety of interventions which would
ideally be combined into locally-appropriate integrated control programs.
Funding for malaria work through USAID has increased dramatically in recent
years, as shown in the following graph.
>
> Strategically, USAID's efforts are focused in five key areas:
>
> -- preventing malaria infection;
> -- promoting effective treatment of malaria illness;
> -- protecting pregnant women from malaria;
> -- responding to the emergence and spread of drug-resistant malaria; and,
> -- addressing the growing threat of malaria posed to populations living in
areas of "complex humanitarian emergencies."
>
> Among the Agency's accomplishments over this time period are:
>
> MANAGING MALARIA ILLNESS IN THE COMMUNITY.  It is estimated that in Africa
up to 80% of people, when seeking medical care, first visit a private drug
outlet or practitioner.  As noted in a recent field study by USAID's Quality
Assurance Project in western Kenya, the technical quality of private medical
and pharmaceutical services is often questionable.  Shops or kiosks were
found to be the main source of drugs for rural people, yet the survey
revealed that 87% of the shopkeepers had never received training on drug use
though 60% routinely gave instructions on dosages to their customers.  The
main reasons for low technical quality of private services is that they are
beyond most governments' capacity to inform, update, monitor, and regulate.
USAID is currently working with the Kenyan Ministry of Health and the Kenyan
NGO AMREF to test new strategies to improve quality of private services
without increasing the burden of government.  It is expected this effort
will provide va!
> luable lessons on how best to reach the private sector, improving the
quality of an important provider of community health services.
>
> SLOWING THE EMERGENCE AND SPREAD OF DRUG RESISTANT MALARIA. The emergence
and spread of multidrug resistant malaria (MDR) across the Mekong region of
Southeast Asia over the past decade and the corresponding increase in deaths
and cases of severe malaria have posed an especially difficult challenge to
planners and policy makers.  As a first step in establishing a regional
capacity to address the threat posed by MDR malaria in the Mekong region
USAID, in partnership with WHO/Roll Back Malaria has established a regional
sentinel surveillance network among the six Mekong countries -- Burma,
Cambodia, China (Yunnan Province), Laos, Thailand and Viet Nam -- for the
routine monitoring and coordinated response to the emergence and spread of
multidrug resistant (MDR) malaria.  In addition, USAID has established
programs in western Cambodia and along the Thai-Burma border to deliver more
effective preventive and curative services among populations most at risk
from MDR malaria.
>
> PROTECTING PREGNANT WOMEN FROM MALARIA.   Each year 22 million African
women who become pregnant in malaria endemic areas are at high risk of
experiencing severe sequelae and additional risk of delivering a low-birth
weight baby - the most common contributing factor to perinatal death.  Yet,
these deaths are easily preventable.  Recent field trials supported by USAID
and conducted by CDC have shown that women can be fully protected from the
risks of malaria infection by taking a two-dose treatment of the
antimalarial drug sulfadoxine-pyrimethamine, SP, at the beginning of their
second and third trimester of pregnancy.  Yet only a few African countries
have adopted policies for the provision of SP through antenatal clinics.
USAID is working to build a "malaria and pregnancy network" to advocate for
wider use of intermittent anti-malarial therapy and is planning on
co-hosting with WHO an Africa regional meeting on expanded MIP activities in
2001.
>
> DEVELOPING SIMPLE AND EFFECTIVE HEALTH TECHNOLOGIES.   USAID's efforts to
improve the health status of children and other vulnerable populations
throughout the developing world are too often constrained by existing
technologies, which may be too expensive, fragile, or rendered ineffective
by adaptive disease pathogens.  The long-term success of health programs
requires the development of simple, effective and affordable interventions.
Among recent USAID accomplishments is the development of low-cost, reliable
malaria diagnostics suitable for use at peripheral health facilities.
Already, they are proving an important new tool for the management of drug
resistance, especially in the Mekong region of Southeast Asia.
>
> ADVANCES IN MALARIA VACCINE DEVELOPMENT.  An entirely new process for
production of a protein malaria vaccine has been developed and human trials
are scheduled. A multi-component DNA vaccine is also ready for human trials.
USAID is playing a leading role in both of these efforts, which are being
conducted at DOD facilities. Following demonstration of safety, field trials
of these vaccines are planned in Kenya and Ghana in 2001.
>
> (end text)
>
> ------
> Public Affairs Section
>
> Jalan Medan Merdeka Selatan 4 Jakarta 10110
> Telephone: (021)3435-9500, Ext. 9566 Fax: (021)381-0243
> e-mail: [EMAIL PROTECTED]
> US Embassy  Homepage: http://www.usembassyjakarta.org
>
>
>
>


---------------------------------------------------------------------
Mulai langganan: kirim e-mail ke [EMAIL PROTECTED]
Stop langganan: kirim e-mail ke [EMAIL PROTECTED]
Archive ada di http://www.mail-archive.com/[email protected]

Kirim email ke